🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Deepinder Goyal commits $25 Mn to longevity venture Continue Research

EntrackrEntrackr · 2m ago
Deepinder Goyal commits $25 Mn to longevity venture Continue Research
Medial

Deepinder Goyal commits $25 Mn to longevity venture Continue Research The project aims to explore ways to extend human life and improve overall health through research on ageing, nutrition, sleep, and mental wellness. Eternal founder and CEO Deepinder Goyal has committed $25 million from his personal wealth to expand his longevity venture, Continue Research. The project aims to explore ways to extend human life and improve overall health through research on ageing, nutrition, sleep, and mental wellness. Continue Research, which began around two years ago, is not a conventional startup but a research-focused initiative and early-stage funding platform. According to Goyal, the fund will back scientists and entrepreneurs working on fundamental biological questions and health tracking technologies. In a post on X, Goyal said the initiative is fully self-funded and intended to support researchers across the world. He described it as a long-term mission to understand human biology better and promote what he calls the “conscious evolution” of humanity. Goyal added that the goal is to significantly improve human longevity and quality of life through sustained scientific exploration. Continue Research will provide seed funding to early-stage teams working in the areas of ageing, health optimisation, and preventive wellness. The initiative plans to invest in projects that aim to slow or reverse aspects of biological ageing and help people live healthier for longer. While Goyal continues to lead Zomato, Continue Research operates independently and is not linked to the company’s parent entity, Eternal. The move marks Goyal’s foray into the longevity and life sciences space, reflecting his growing interest in deep science and the long-term future of human health.

14

Related News

Ultrahuman Raises $35 Mn To Boost Research In Health Monitoring

Inc42Inc42 · 1y ago
Ultrahuman Raises $35 Mn To Boost Research In Health Monitoring
Medial

Bengaluru-based fitness and healthtech platform, Ultrahuman, has raised $35 million in a mix of debt and equity funding in a Series B round. The funding round included participation from investors such as Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave, and Zomato founder Deepinder Goyal. Ultrahuman plans to use the funds to expand its manufacturing capacity and conduct further research in the health tracking space. The startup offers health tracking and monitoring devices, including fitness rings, and aims to become the market leader in the smart rings space. Ultrahuman also provides a subscription-based fitness platform for better data monitoring and offers a range of workout content.

Deepinder Goyal to enter health and mental fitness space with ‘Continue’

EntrackrEntrackr · 1y ago
Deepinder Goyal to enter health and mental fitness space with ‘Continue’
Medial

Zomato co-founder and chief executive officer Deepinder Goyal has incorporated a new venture named Continue, which will focus on health tracking and mental wellness. However, the new venture is purely personal, with no Zomato involvement. Launched in April 2024 under the legal name Upslove Advisors Private Limited, the company’s shareholders—Deepinder Goyal (holding 99.9%) and Ashish Gotal (holding 0.1%)—contributed an initial capital of Rs 50 lakhs, as per a regulatory filing accessed from the Registrar of Companies (RoC) The domain Continue.com, marketed as “The Ultimate Health Tracker,” currently provides no additional details. The domain was registered under the new entity Upslove Advisors Private Limited. According to the RoC, Deepinder Goyal being the active director while Simrandeep Singh and Akriti Mehta have been appointed as additional directors of Upslove Advisors Private Limited. Based on their LinkedIn profiles, both Singh and Mehta have been with Zomato for the past 5 and 7 years, respectively. The new venture, Continue, is set to compete with Ultrahuman and Mindhouse, founded by former Zomato COO Mohit Kumar and co-founder Pankaj Chaddah, respectively. Notably, Goyal pumped in $10 million in Ultrahuman’s Series B funding. Zomato has shown a strong interest in the health and fitness segment, having previously acquired Fitso, which it later sold to Tata Digital-owned Curefit. With the launch of Continue (health), Deepinder Goyal now has his foot in several sectors, including food delivery (Zomato), quick commerce (BlinkIt), entertainment and ticketing (District), and B2B supplies (HyperPure). In July, Goyal entered the billionaire dollar club as the value of his holdings in Zomato surpassed Rs 8,400 crore ($1 billion). The move into new ventures might be surprising to some, as Zomato is hardly in cruise control mode as a business, despite moving into profits. The business remains volatile, with many issues that need addressing, besides sustaining profitability. Add to that the continuous parade of ‘co-founder’ exits, and one would imagine Goyal would have given a lot of thought to the move into a new personal project. The collegiate environment that has been projected at Zomato however fits in well with the move, with the firm showing a willingness to back ex-employees with ideas. One assumes Goyal has a plan to dilute his holdings in favour of relevant people who make an impact at Continue like the other ventures he has backed, without distracting him from his main job of running Zomato, as investors in the latter will also be hoping.

Decode Age raises $1.7 Mn in pre-Series A round

EntrackrEntrackr · 9d ago
Decode Age raises $1.7 Mn in pre-Series A round
Medial

Snippets Decode Age raises $1.7 Mn in pre-Series A round Bengaluru-based longevity science startup Decode Age has raised Rs 14.48 crore (around $1.7 million) in a pre-Series A round led by Krishna Prasad Chigurupati, chairman and managing director of Granules India. Founded in 2021, Decode Age works at the intersection of aging biology, biomarkers, and gut microbiome science. The company focuses on making ageing-related biological signals measurable and usable through testing, research, and precision-led interventions. The proceeds will be used to expand Decode Age’s biomarker discovery programmes, strengthen its multi-omics and microbiome research pipeline, and upgrade scientific and analytical infrastructure. The firm is also working on research-backed supplements and longevity solutions linked to aging pathways such as metabolism, inflammation, cellular energy, and cognitive health. Decode Age has built an in-house platform covering genome-scale gut microbiome analysis, metagenomics, and biomarker research. Its systems are designed to support clinicians, researchers, and individuals seeking data-driven insights into long-term health and aging. The startup is also expanding its scientific and product teams as it looks to take its longevity research beyond India. It collaborates with academic and global research initiatives, including work linked to IISc and international longevity programmes, to generate microbiome and ageing data aligned with global research standards.

Download the medial app to read full posts, comements and news.